. 2017 May 19;37(3):BSR20170150. doi: 10.1042/BSR20170150

Table 3. Subpopulation proportions delineated by FSC/SSC (central), FSC/SSC (extended) strategies in normal pregnancy and URM.

Marker	Cell	FSC/SSC (central)		FSC/SSC (extend)
		Normal pregnancy	URM	Normal pregnancy	URM
CD3⁺CD56^–	T	28.4 ± 3.2	27.5 ± 3.1	21.5 ± 2.4	23.3 ± 2.7
CD3^–CD56^brightCD16^–	dNK	39.2 ± 4.6	46.6 ± 4.6	45.4 ± 3.7	49.6 ± 3.7
CD3^–CD56^brightCD16^–/CD3⁺CD56^–	dNK/T	1.5 ± 0.5	1.8 ± 0.2	2 ± 0.2	2.0 ± 0.2
CD3⁺CD56⁺	NKT-like	6.9 ± 0.9	6.2 ± 1.5	7.5 ± 0.7	7.4 ± 1.5
CD3⁺CD4⁺CD8^–	Th	53.9 ± 2.1	47.9 ± 1.9	54.0 ± 2.0	48.3 ± 1.7
CD3⁺CD4^–CD8⁺	Tc	27.9 ± 1.6	28.5 ± 1.9	28.1 ± 1.5	26.7 ± 1.7
CD3⁺CD4⁺CD8^–/CD3⁺CD4^–CD8⁺	Th/Tc	2 ± 0.2	1.8 ± 0.2	2.1 ± 0.1	1.9 ± 0.2
CD3⁺CD4⁺CD8^–IFN-γ⁺IL-4^–	Th1	37.4 ± 2.5	43.9 ± 1.8	34.8 ± 1.9	42.7 ± 1.7
CD3⁺CD4⁺CD8^–IFN-γ^–IL-4⁺	Th2	1.2 ± 0.3	0.4 ± 0.1	0.8 ± 0.2	0.9 ± 0.2
CD3⁺CD4⁺CD8^–IFN-γ⁺IL-4⁺	Th DP^*	4.8±0.7	3.8 ± 0.9	3.2 ± 0.4	5.6 ± 1.1
CD3⁺CD4⁺CD8^–IFN-γ⁺IL-4^– /CD3⁺CD4⁺CD8^–IFN-γ^–IL-4⁺	Th1/Th2	74.3 ± 14.6	167.0 ± 11.5	103.4 ± 23.0	82.5 ± 15.2
CD3⁺CD4^–CD8⁺IFN-γ⁺IL-4^–	Tc1	49.5 ± 2.8	57.1±3.6	43.7±2.4	56.8 ± 2.9
CD3⁺CD4^–CD8+IFN-γ^–IL-4⁺	Tc2	1.4 ± 0.3	2.0±1.4	3.9±0.9	2.1 ± 0.8
CD3⁺CD4^–CD8+IFN-γ⁺IL-4⁺	Tc DP^*	2.9 ± 0.5	1.6 ± 0.4	3.3 ± 0.5	3.1 ± 0.6
CD3⁺CD4⁻CD8+IFN-γ⁺IL-4⁻/CD3⁺CD4^– CD8+IFN-γ^–IL-4⁺	Tc1/Tc2	83.4 ± 18.5	113.7 ± 11.9	28.0 ± 5.6	39.4 ± 7.8
CD3^–CD56^brightCD16^–IFN-γ⁺IL-4^–	dNK1	9.2 ± 1.3	8.1 ± 2.0	5.2 ± 1.1	9.9 ± 2.2
CD3^–CD56^brightCD16^–IFN-γ^–IL-4⁺	dNk2	3.2 ± 0.7	0.7 ± 0.2	8.4 ± 1.4	4.0 ± 0.7
CD3^–CD56^brightCD16^–IFN-γ⁺IL-4⁺	dNK DP^*	0.2 ± 0.1	0.01 ± 0.006	0.3 ± 0.1	0.3 ± 0.1
CD3^–CD56^brightCD16^–IFN-γ⁺IL-4^– /CD3^–CD56^brightCD16^–IFN-γ^–IL-4⁺	dNk1/dNK2	11.2 ± 3.2	72.1 ± 12.1	3.5 ± 1.6	5.7 ± 2.8

*DP represents double positive cell.